SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 47 filers reported holding SIGILON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $688,962 | +165.7% | 740,740 | 0.0% | 0.23% | +166.7% |
| Q4 2022 | $259,259 | -30.7% | 740,740 | 0.0% | 0.09% | -28.7% |
| Q3 2022 | $374,000 | -39.2% | 740,740 | 0.0% | 0.12% | -39.6% |
| Q2 2022 | $615,000 | -43.5% | 740,740 | 0.0% | 0.20% | -9.0% |
| Q1 2022 | $1,089,000 | -46.7% | 740,740 | 0.0% | 0.22% | -14.9% |
| Q4 2021 | $2,044,000 | -51.2% | 740,740 | 0.0% | 0.26% | -33.6% |
| Q3 2021 | $4,185,000 | -47.3% | 740,740 | 0.0% | 0.39% | -48.3% |
| Q2 2021 | $7,948,000 | -52.0% | 740,740 | 0.0% | 0.76% | -65.8% |
| Q1 2021 | $16,556,000 | -53.5% | 740,740 | 0.0% | 2.22% | -84.0% |
| Q4 2020 | $35,578,000 | – | 740,740 | – | 13.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|